Pfizer and Cipla are teaming up with the American Cancer Society and the Clinton Health Access Initiative to provide cheap chemotherapy drugs to six nations in Africa that have been hit the hardest by treatable cancers. They’re taking inspiration from Pepfar, which is the (US) President’s Emergency Plan for AIDS Relief, and not a program designed to export pep rallies far across the globe. Pepfar is responsible for many of the 14 million Africans who now have access to HIV medications, and the above collaboration is keen to replicate that kind of success. The drug companies will sell 16 generic chemotherapies at a fraction of what they cost in more well-off countries—minimizing profits, but maximizing positive PR. Needless to say: well done, all involved.